Panasas today released Dynamic Data Acceleration on the new PanFS parallel file system, a proprietary software feature that delivers predictable performance by automatically adapting to the changing and evolving small file and mixed workloads found in today's HPC and AI workloads
Researchers at the UC San Diego Center for Microbiome Innovation (CMI), have expanded their Panasas high-performance computing (HPC) storage infrastructure with an additional two petabytes (PB) of ActiveStor data storage to support the growing number of I/O-intensive tasks related to COVID-19 research
Advances in storage technology enable scientists to accelerate their research
A research report from Hyperion Research, commissioned by Panasas, has found that that total cost of ownership (TCO) is rising as a top criterion for purchasing high-performance computing (HPC) storage systems.
Panasas, a provider of high-performance computing (HPC) data storage solutions, has announced that it has received a new round of private equity investment
Panasas a provider of high-performance scale-out network-attached storage (NAS), has announced the appointment of Rob Berman as the company’s vice president of sales for the Americas
Robert Roe finds that commoditisation of flash and SSD technology and the uptake of machine learning and AI applications are driving new paradigms in storage technology.
Panasas, a specialist in high-performance scale-out network-attached storage (NAS), today introduced ActiveStor 20, its latest generation hybrid scale-out NAS appliance, featuring a 65 per cent increase in flash and a 25 per cent increase in hard drive capacity
Panasas, the leader in hybrid scale-out NAS for enterprise and research environments, today announced it has appointed David Sallak as its new vice president of industry marketing
Panasas is the premier provider of high performance scale-out storage solutions for big data workloads. All Panasas storage appliances leverage Panasas® PanFS™ parallel file system to deliver superior performance, data protection, scalability, and manageability.
Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
